SAS has made the top spot in Fortune magazine's list of Best Places to Work for the second year in a row.

The Cary software company has made the list for 14 years and earned the top spot with its legendary perks such as on-site healthcare and summer camp for kids.

Earlier this week, the private company projected that revenue would rise by 12 percent this year.  SAS does not disclose profits. Projected growth has the company planning to build on its campus in about a year.

SAS employs 12,370 workers worldwide; 4,818 in Cary.

Other companies with a local presence that made the Fortune list include Cisco and Whole Foods. To see the complete list, go here.

Business software company SAS, which for years has been a fixture on Fortune magazine's list of the best companies to work for, has again ranked No. 1 on the 2011 list.

SAS also ranked No. 1 last year.

SAS is one of the largest companies in the Triangle with nearly 11,500 workers worldwide, including more than 4,650 at its Cary headquarters. The company's business intelligence and analytics software is used by corporations and other customers to analyze their operations and forecast trends.

"This high honor rounds out a tremendous year for us at SAS," CEO Jim Goodnight said in a release. "We delivered more software in 2010 than ever before in our history and grew our work force by 2.4 percent. Our employees are the lifeline of our success."

Second behind SAS on this year's Fortune list was Boston Consulting Group followed by Wegmans Food Markets, Google and NetApp and the online shoe retailer Zappos.com.

Along with NetApp, which has operations in Research Triangle Park, other companies with a Triangle presence that made the top 100 list include: Cisco Systems (No. 20) and the Danish pharmaceutical company Novo Nordisk (No. 47).

Deirdre Connelly continues her climb on Fortune magazine's annual list of the 50 Most Powerful Women in Business.

Connelly, 50, a top executive at GlaxoSmithKline, rose to No. 27 on this year's list, up 10 spots from last year.

As president of North American pharmaceuticals for the British company, Connelly oversees GSK's Triangle operations and its 5,000 employees in Research Triangle Park and Zebulon.

She reports to CEO Andrew Witty and is responsible for helping GSK scientists find promising new drugs and boosting sales of existing products.

As Fortune notes, Connelly's "$15-billion-a-year business hinges on its respiratory franchise. The hope: that Relovair, now in clinical trials, replaces Advair, the blockbuster GSK drug whose patent soon expires."